Drug use-associated infective endocarditis (DUA-IE) is a major cause of illness and death
for people with substance use disorder (SUD). Investigations to date have largely focused …

Importance Serious injection-related infections (SIRIs) cause significant morbidity and
mortality. Medication for opioid use disorder (MOUD) improves outcomes but is underused …

Introduction Hospitalizations for severe injection-related infections (SIRI), such as
endocarditis, osteomyelitis, and skin and soft tissue infections (SSTI) are increasingly …

Background To address the infectious disease (ID) and substance use disorder (SUD)
syndemic, we developed an integrated ID/SUD clinical team rooted in harm reduction at a …

OBJECTIVES: To describe practice patterns surrounding the use of medications to treat
opioid use disorder (MOUD) in critically ill patients. DESIGN: Retrospective, multicenter …

Background Hospitalizations for severe injection drug use-related infections (SIRIs) are
characterized by high costs, frequent patient-directed discharge, and high readmission …

Patients with injection drug use-associated infective endocarditis and opioid use disorder
often receive treatment for the infection that fails to address its underlying cause. People …

Background The incidence of infective endocarditis (IE) and other systemic bacterial
infections is increasing, and people who inject drugs (PWID) have higher rates of discharge …

Background Hospitals are an essential site of care for people with opioid use disorder
(OUD). Buprenorphine and methadone are underutilized in the hospital. Objectives …

and some inpatients' use of unregulated substances prompt clinical and ethical questions
considered in this commentary on a case. Short-acting opioids can be used to manage …